Secondary metabolites from Lobaria pulmonaria (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis

Key Points

• The aim is to explore the use of secondary metabolites from Lobaria pulmonaria for treating multidrug-resistant tuberculosis.
• Examined the traditional use of Lobaria pulmonaria in tuberculosis treatment.
• Identified key metabolic enzymes targeted by secondary metabolites.
• Investigated the efficacy of these metabolites against multidrug-resistant strains.
• Secondary metabolites from Lobaria pulmonaria show potential in inhibiting key metabolic enzymes.
• These findings highlight a novel strategy for combating multidrug-resistant tuberculosis.